Infectious Disease Screening
Conditions
Keywords
nucleic acid, pre-transfusion, pre-operative, pathogen detection
Brief summary
In the past ten years, nucleic acid detection technology has overcome the limitations of serological detection, reduced missed detections due to window period, occult infection, etc., and its application in the field of pathogen detection has developed rapidly. Since 2015, domestic blood collection and supply institutions have fully popularized nucleic acid testing. The safety screening of blood sources mostly adopts the method of combining two times of enzyme-free negative and one time of nucleic acid testing, which excludes the guarantee of blood safety to the greatest extent. At present, the clinical pre-transfusion and pre-operative infectious disease screening in our country is still serological detection. The use of nucleic acid detection for infectious disease screening can better realize the significance of patients' pre-transfusion/pre-operative infectious disease screening. Therefore, this study will analyze the nucleic acid detection technology and clinical serological detection technology in order to solve three problems: * Explore the best detection strategy for patients with pre-transfusion/pre-operative infectious disease screening; ② Explore the confirmation process of the gray area results of infectious disease serological testing; ③ Better realize the significance of screening for patients' infectious diseases.
Interventions
DIAGNOSTIC_TESTinfectious disease screening
Explore the best detection strategy for patients with pre-transfusion/pre-operative infectious disease screening
Sponsors
SANSURE BIOTECH INC.
The Third Xiangya Hospital of Central South University
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
1 Years to 100 Years
Healthy volunteers
Yes
Inclusion criteria
* hosipital patients
Exclusion criteria
* No
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hepatitis B Infection Analysis result | 20190601-20201231 | Nucleic acid examination and serological test |
| Hepatitis C Infection Analysis result | 20190601-20201231 | Nucleic acid examination and serological test |
| HIV Infection Analysis result | 20190601-20201231 | Nucleic acid examination and serological test |
Countries
China
Outcome results
None listed